Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
From CNBC.com News
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
From CNBC.com News
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
May 02, 2024
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
From CNBC.com News
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
April 24, 2024
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
April 20, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
April 12, 2024
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
April 04, 2024
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
April 04, 2024
From CNBC.com News
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
March 27, 2024
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
March 27, 2024
From CNBC.com News
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
From CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
March 23, 2024
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
From CNBC.com News
Cramer's Lighting Round: Arm is a buy
March 22, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.